(NASDAQ: EMBC) Embecta's forecast annual revenue growth rate of 0.94% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 12.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.18%.
Embecta's revenue in 2026 is $1,079,700,000.On average, 6 Wall Street analysts forecast EMBC's revenue for 2026 to be $65,260,279,108, with the lowest EMBC revenue forecast at $62,476,945,970, and the highest EMBC revenue forecast at $67,332,973,998. On average, 6 Wall Street analysts forecast EMBC's revenue for 2027 to be $65,437,938,670, with the lowest EMBC revenue forecast at $62,832,265,094, and the highest EMBC revenue forecast at $67,451,413,706.
In 2028, EMBC is forecast to generate $65,793,257,794 in revenue, with the lowest revenue forecast at $63,187,584,218 and the highest revenue forecast at $67,688,293,122.